Condition

Advanced Solid Tumors (1)

BRAF-Mutated Melanoma (1)

Colorectal Carcinoma (1)

EGFR Positive Non-small Cell Lung Cancer (1)

Recurrent Ovarian Carcinoma (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Sumitomo Pharma Oncology, Inc. (1)

Collaborator

Intervention

tp-0903 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

EGFR Positive Non-small Cell Lung Cancer

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS